Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7637972 | 0.81 | — | — | |
| SCHEMBL5619506 | 0.76 | — | — | |
| SCHEMBL2112377 | 0.73 | TSHR (0.36) | MEN1KMT2AMAPTTDP1NPSR1 | |
| SCHEMBL97013 | 0.73 | — | — | |
| SCHEMBL27029724 | 0.70 | — | — | |
| SCHEMBL648441 | 0.69 | MAPT (0.39) | MEN1KMT2AMAPTPOLBTDP1 | |
| SCHEMBL3131843 | 0.69 | — | — | |
| SCHEMBL3752904 | 0.69 | — | — | |
| SCHEMBL3104027 | 0.69 | — | — | |
| SCHEMBL3752663 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11695158-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | MU IONIC SOLUTIONS CORPORATION (JP) | 2023-07-04 | — | — | US | disclosed |
| US-20210320334-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | MU IONIC SOLUTIONS CORPORATION (JP) | 2021-10-14 | — | — | US | disclosed |
| US-20190198928-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | UBE INDUSTRIES, LTD. (JP) | 2019-06-27 | — | — | US | disclosed |
| EP-3086396-B1 | NONAQUEOUS ELECTROLYTE WITH CARBOXYLIC ACID ESTER COMPOUND AND ENERGY STORAGE DEVICE USING SAME | UBE INDUSTRIES (JP) | 2019-06-05 | — | — | EP | disclosed |
| US-10263285-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | UBE INDUSTRIES, LTD. (JP) | 2019-04-16 | — | — | US | disclosed |
| US-20180166746-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | UBE INDUSTRIES, LTD. (JP) | 2018-06-14 | — | — | US | disclosed |
| EP-3086396-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | UBE Industries, Ltd. (JP) | 2016-10-26 | — | — | EP | disclosed |
| EP-1583767-B1 | NEW PHOSPHORAMIDE DERIVATIVES | PALAU PHARMA SA (ES) | 2010-07-07 | — | — | EP | disclosed |
| US-7550497-B2 | sulfonamidophosphonate-functional heteroaryl compounds that contain SO2-NH-P(O)(-OR)2 group; antiinflammatory and analgesics; e.g. N-[4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]phenylsulfonyl]phosphoramidic acid; injectable COX-2 inhibitors | PALAU PHARMA, S.A. (ES) | 2009-06-23 | — | — | US | disclosed |
| US-20060111326-A1 | New phosphoramide derivatives | J. URIACH Y COMPANIA S.A. (ES) | 2006-05-25 | — | — | US | disclosed |
| EP-1583767-A1 | NEW PHOSPHORAMIDE DERIVATIVES | J. Uriach y Compania S.A. (ES) | 2005-10-12 | — | — | EP | disclosed |
| WO-2004058778-A1 | NEW PHOSPHORAMIDE DERIVATIVES | J. Uriach Y Compañia S.A. (ES) | 2004-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180166746-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | SLC9A2, VDAC1, SCO2 | MEN1 3123/4885KMT2A 1930/4885MAPT 4839/4885 |
| US-20190198928-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | SLC9A2, VDAC1, SCO2 | MEN1 3123/4885KMT2A 1930/4885MAPT 4839/4885 |
| US-11695158-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | SLC9A2, VDAC1, SCO2 | MEN1 3123/4885KMT2A 1930/4885MAPT 4839/4885 |
| US-10263285-B2 | Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same | SLC9A2, VDAC1, SCO2 | MEN1 3123/4885KMT2A 1930/4885MAPT 4839/4885 |
| US-20210320334-A1 | NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME | SLC9A2, VDAC1, SCO2 | MEN1 3123/4885KMT2A 1930/4885MAPT 4839/4885 |
| US-20060111326-A1 | New phosphoramide derivatives | P2RY10, P2RY1, TRPV1 | MEN1 3962/4885KMT2A 3571/4885MAPT 2141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.